EU/3/19/2134

Table of contents

About

On 26 February 2019, orphan designation (EU/3/19/2134) was granted by the European Commission to FGK Representative Service GmbH, Germany for 9-cis, 12-cis-11,11-D2-linoleic acid ethyl ester (also known as RT001) for the treatment of infantile neuroaxonal dystrophy.

Key facts

Active substance
9-cis, 12-cis-11,11-D2-linoleic acid ethyl ester
Disease / condition
Treatment of infantile neuroaxonal dystrophy
Date of first decision
26/02/2019
Outcome
Positive
EU designation number
EU/3/19/2134

Sponsor's contact details

FGK Representative Service GmbH
Heimeranstrasse 35
80339 Munich
Germany
Tel.+49 8989 311928
E-mail: clinical.studies@fgk-rs.com

Patients' organisations

For contact details of patients’ organisations whose activities are targeted at rare diseases, see:

  • European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.

  • Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.

How useful was this page?

Add your rating